4 November 2021 - EffRx Pharmaceuticals today announced that Swissmedic has approved Bronchitol (inhaled mannitol) for the treatment of cystic fibrosis in adults and in children aged 6 years and above as add‐on to other medicines.
EffRx expects the availability of Bronchitol in Switzerland in the second half of 2022.